Bergeron M G, Bergeron Y, Beauchamp D
Service d'Infectiologie, Le Centre Hospitalier de l'Université Laval, Quebec, Canada.
Antimicrob Agents Chemother. 1987 Nov;31(11):1816-21. doi: 10.1128/AAC.31.11.1816.
Gentamicin is a commonly used antibiotic in the treatment of gram-negative infections including septicemia and pyelonephritis. Bacterial endotoxin is liberated during antibiotic therapy and may lead to endotoxemic shock. Steroids such as hydrocortisone are generally recommended in the treatment of endotoxemic shock. There are very limited data on the influence of endotoxin or corticosteroids on the pharmacology of antibiotics, especially aminoglycosides, which are nephrotoxic. We studied the influence of both Escherichia coli endotoxin and hydrocortisone succinate on the renal uptake of gentamicin in rats. Animals were injected intravenously with endotoxin (0.25 mg/kg) and/or hydrocortisone (25 mg/kg) plus gentamicin (10 mg/kg). Gentamicin levels in the serum and renal parenchyma as well as renal function and histology were evaluated. Both endotoxin and hydrocortisone given alone increased the concentration of gentamicin in the renal cortex (P less than 0.05). Normal values in serum were observed in all groups at most time intervals. When administered together, endotoxin and hydrocortisone did not potentiate each other. The combination of endotoxin and hydrocortisone gave significantly higher levels of gentamicin than endotoxin or hydrocortisone alone when endotoxin was injected 3 h before hydrocortisone (P less than 0.05). Blood pressure and cardiac frequency were normal when gentamicin was given. Endotoxin alone slightly decreased the glomerular filtration rate, and hydrocortisone alone slightly modified renal plasma flow. The combination of both drugs did not significantly affect renal function. No histological lesion was noted on light microscopy in animals receiving endotoxin. Competitive or synergistic activity of endotoxin, gentamicin, and hydrocortisone at the cellular level, especially on membranes or lysosomes, might explain in part our observation on the renal uptake of gentamicin. By increasing the total amount of drug within the kidney, endotoxin and hydrocortisone might increase the risk of nephrotoxicity associated with aminoglycosides.
庆大霉素是治疗革兰氏阴性菌感染(包括败血症和肾盂肾炎)常用的抗生素。在抗生素治疗期间,细菌内毒素会释放出来,可能导致内毒素血症休克。通常推荐使用氢化可的松等类固醇来治疗内毒素血症休克。关于内毒素或皮质类固醇对抗生素(尤其是具有肾毒性的氨基糖苷类抗生素)药理学影响的数据非常有限。我们研究了大肠杆菌内毒素和琥珀酸氢化可的松对大鼠肾脏摄取庆大霉素的影响。给动物静脉注射内毒素(0.25mg/kg)和/或氢化可的松(25mg/kg)加庆大霉素(10mg/kg)。评估血清和肾实质中的庆大霉素水平以及肾功能和组织学情况。单独给予内毒素和氢化可的松均会增加肾皮质中庆大霉素的浓度(P<0.05)。在大多数时间间隔,所有组的血清值均正常。当一起给药时,内毒素和氢化可的松不会相互增强作用。当在内毒素注射3小时后注射氢化可的松时,内毒素和氢化可的松联合使用时的庆大霉素水平明显高于单独使用内毒素或氢化可的松时(P<0.05)。给予庆大霉素时血压和心率正常。单独使用内毒素会轻微降低肾小球滤过率,单独使用氢化可的松会轻微改变肾血浆流量。两种药物联合使用对肾功能没有显著影响。接受内毒素的动物在光学显微镜下未发现组织学病变。内毒素、庆大霉素和氢化可的松在细胞水平(尤其是在细胞膜或溶酶体上)的竞争或协同活性可能部分解释了我们对庆大霉素肾脏摄取的观察结果。通过增加肾脏内药物的总量,内毒素和氢化可的松可能会增加与氨基糖苷类药物相关的肾毒性风险。